Biotechnology firm Bicycle Therapeutics has appointed Peter Leone as chief business officer (CBO) and promoted Lee Kalowski from chief financial officer (CFO) to president of the company's U.S. subsidiary.
The announcements come as Rosamond Deegan, former president and CBO, has stepped away from the company to pursue another executive leadership position in biotech.
Leone most recently served as vice president of strategic business initiatives at Arrowhead Pharmaceuticals and previously held the position of chief operating officer at Alvos Therapeutics.
Kalowski joined Bicycle as CFO in 2017. Prior to Bicycle, he served as CFO at Tokai Pharmaceuticals, and he was also vice president of global biotechnology equity research at Credit Suisse.
